Mutation News and Research

RSS

New system solves 3D structures of RNA-only molecules with unprecedented speed and accuracy

The single-stranded genetic material RNA is best known for guiding the assembly of proteins in our cells and carrying the genetic code for viruses like SARS-CoV-2 and HIV.

16 Aug 2021

New technique to hunt down mutations that cause cancer drug resistance

Using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on the resistance that inevitably develops to cancer drugs that target them, a new study led by UT Southwestern scientists suggests.

11 Aug 2021

Experimental small molecule could help treat Parkinson’s disease in future

A new study has demonstrated the removal of damaged mitochondria from the brain cells of mice treated with a small molecule compound for Parkinson’s disease.

5 Aug 2021

Study reveals melanoma is associated with a chemical conversion in DNA

According to recent research, the mutations giving rise to melanoma are the outcome of a chemical conversion in DNA triggered by sunlight.

3 Aug 2021

Study shows promising results for treating muscular dystrophies with umbilical cord-derived MSCs

Results of a compassionate-use study released in STEM CELLS Translational Medicine show promising results for treating muscular dystrophies with mesenchymal stem cells (MSCs) derived from Wharton's jelly (WJ), a substance found in the umbilical cord.

28 Jul 2021

New thin-film microfluidic device to manipulate β-lactoglobulin in milk

Researchers have manipulated beta-lactoglobulin, or β-lactoglobulin, by using an Australian-made innovative thin-film microfluidic device.

27 Jul 2021

Study applies novel AI tool to primary cancer genomes to identify mutation history

A new study has investigated the fragments of cancer DNA that arise from the human genome, the sequence of which is the outcomes of millions of years of evolution.

26 Jul 2021

Toward an antiviral drug that works against all coronaviruses

Safe and effective vaccines offer hope for an end to the COVID-19 pandemic. However, the possible emergence of vaccine-resistant SARS-CoV-2 variants, as well as novel coronaviruses, make finding treatments that work against all coronaviruses as important as ever.

22 Jul 2021

L452R mutation of SARS-CoV-2 spike protein is involved in cellular immunity evasion

A research team has demonstrated that the L452R mutation of the SARS-CoV-2 spike protein plays a role in cellular immunity evasion.

21 Jul 2021

Study reveals neurotransmitter releases impairments in schizophrenia patients

A research team revealed that neurotransmitter release in the brain is impaired in patients with schizophrenia who possess a rare, single-gene mutation.

16 Jul 2021

Researchers identify gene responsible for vicine-convicine content in faba beans

Faba beans are exceptional sources of food protein; however, around 4 % of the world’s population is affected by favism.

12 Jul 2021

Emerging variants of COVID-19 could be treated with a new anticoagulant drug

The capacity of the COVID-19 virus’s spikes to bind to human cells may be hampered by molecules from the same family as the anticoagulant medication heparin.

9 Jul 2021

Study identifies the gene responsible for toxic vicine and convicine production in faba beans

Faba beans have been a good source of protein. A team of experts has now found the gene that causes the toxic vicine and convicine to be produced.

7 Jul 2021

CRISPR-Cas9 system could help perform very effective target gene silencing

CRISPR-Cas9's extraordinary ability to modify specific areas of DNA has made it a favorite among gene-editing tools for researchers.

6 Jul 2021

New tool sheds light on enzymatic activity linked to blood cancers, heart disease

Scientists have provided a better understanding of a process in immune cells that could help explain why certain people develop cardiovascular disease.

28 Jun 2021

New methodology assesses whole-genome sequencing data of SARS-CoV-2 mutations

According to researchers from Harvard T.H. Chan School of Public Health and MIT, the use of genome-wide association studies (GWAS) methodology to assess whole-genome sequencing data of SARS-CoV-2 mutations and COVID-19 mortality data can help identify highly pathogenic variants of the virus that should be flagged for containment.

25 Jun 2021

Mutation News and Research

New system solves 3D structures of RNA-only molecules with unprecedented speed and accuracy

New technique to hunt down mutations that cause cancer drug resistance

Experimental small molecule could help treat Parkinson’s disease in future

Study reveals melanoma is associated with a chemical conversion in DNA

Study shows promising results for treating muscular dystrophies with umbilical cord-derived MSCs

New thin-film microfluidic device to manipulate β-lactoglobulin in milk

Study applies novel AI tool to primary cancer genomes to identify mutation history

Toward an antiviral drug that works against all coronaviruses

L452R mutation of SARS-CoV-2 spike protein is involved in cellular immunity evasion

Study reveals neurotransmitter releases impairments in schizophrenia patients

Researchers identify gene responsible for vicine-convicine content in faba beans

Emerging variants of COVID-19 could be treated with a new anticoagulant drug

Study identifies the gene responsible for toxic vicine and convicine production in faba beans

CRISPR-Cas9 system could help perform very effective target gene silencing

New tool sheds light on enzymatic activity linked to blood cancers, heart disease

New methodology assesses whole-genome sequencing data of SARS-CoV-2 mutations

New nanobodies could fight against SARS-CoV-2 variants

Single mutation leads to rare genetic muscle disease

Study reveals molecular factors that allow birds to fly

Harmful DNA mutations play a key role in the conservation of threatened species

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics